Mega Genomics Limited (HKG:6667)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.23
+0.21 (2.99%)
Apr 29, 2026, 1:32 PM HKT
0.42%
Market Cap 1.57B
Revenue (ttm) 275.03M
Net Income (ttm) 30.07M
Shares Out 224.30M
EPS (ttm) 0.15
PE Ratio 46.10
Forward PE n/a
Dividend 0.17 (2.45%)
Ex-Dividend Date n/a
Volume 2,600
Average Volume 1,730
Open 7.23
Previous Close 7.02
Day's Range 7.23 - 7.23
52-Week Range 6.19 - 7.53
Beta 0.81
RSI 52.28
Earnings Date Mar 31, 2026

About Mega Genomics

Mega Genomics Limited, a genetic testing platform company, offers consumer genetic testing and cancer screening services in China. It offers brain health assessment package, a service that assesses the risk of various related diseases, including Alzheimer’s disease; alimentation capability assessment package, a service that assesses the risk of developing hyperhomocysteinemia; Parkinson’s disease risk assessment; full-scale cancer risk assessment packages; myocardial infarction and heart failure genetic testing, a service and ancillary service ... [Read more]

Sector Healthcare
Founded 2016
Employees 203
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6667
Full Company Profile

Financial Performance

In 2025, Mega Genomics's revenue was 247.15 million, an increase of 50.49% compared to the previous year's 164.23 million. Earnings were 27.02 million, a decrease of -40.01%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.